| Vaccines |
1 |
1 |
| Cancer |
0 |
0.9 |
| Targeted Cancer Therapy |
0 |
0.69 |
| Cancer Risk |
0 |
0.68 |
| Breast Cancer |
0 |
0.57 |
| COVID-19 |
0 |
0.95 |
| Toxicology |
0 |
0.48 |
| Blood |
0 |
0.17 |
| Tumor |
0 |
0.17 |
| Immunization |
0 |
0.8 |
| Stem Cell Research and Therapy |
0 |
0.11 |
| Chemotherapy |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Food and Drug Administration (FDA) |
0 |
0.1 |
| Multiple Myeloma |
0 |
0.1 |
| T-Lymphocyte |
0 |
0.1 |
| Transplantation |
0 |
0.1 |
| CAR-T |
0 |
0.09 |
| Organ Transplantation |
0 |
0.09 |
| Clinical Guidelines |
0 |
0.07 |
| New York |
0 |
0.07 |
| Tyrosine Kinase Inhibitor |
0 |
0.05 |
| Antimetabolite |
0 |
0.03 |
| Breast |
0 |
0.03 |
| Decompression Sickness |
0 |
0.03 |
| Dialysis |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Hemodialysis |
0 |
0.03 |
| Immunocompromise |
0 |
0.03 |
| Immunosuppressive Therapy |
0 |
0.03 |
| Immunotherapy |
0 |
0.03 |
| Lymphocytes |
0 |
0.03 |
| Monoclonal Antibody |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Radiation Therapy |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |
| Social Distancing |
0 |
0.03 |
| Tetanus |
0 |
0.03 |
| Texas |
0 |
0.03 |
| Tyrosine Kinase |
0 |
0.03 |
| Varicella-Zoster Virus |
0 |
0.03 |